Yang Yang

The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse

Yawen Wang, Jiadai Xu, Bei Xu et al. · Cancer · 2023 · 31 citations · Full text

Life Sciences, Genetics, Hematology +15

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

Jing Li, Li Bao, Zhongjun Xia et al. · Annals of Hematology · 2020 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides

Jiadai Xu, Tianhong Xu, Yang Yang et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 17 citations

Medicine, Hematology, Oncology +12

A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients

Liang Ren, Jiadai Xu, Jing Li et al. · Clinical and Experimental Medicine · 2023 · 14 citations

Medicine, Immunology, Oncology +16

Integrative analysis of prognostic factors in Chinese core binding factor leukemia

Di Wang, Chun Qiao, Min Xiao et al. · Biochemical and Biophysical Research Communications · 2012 · 10 citations

Medicine, Cancer Biology, Oncology +11